Search

Meeting Coverage:

American Academy of Ophthalmology

AAO: 2019

PANORAMA Study Data

Rishi P. Singh, MD

Show Description +

Rishi P. Singh, MD, reviews 52-week data from the PANORMA study, which assessed response to therapy in patients with nonproliferative diabetic retinopathy without diabetic macular edema who were treated with aflibercept. Patients were treated every 8 or 16 weeks with aflibercept or sham and were evaluated for 2-step improvements in retinopathy scoring.

Posted: 9/13/2019

Keywords:

aflibercept

•

Diabetic macular edema, DME

•

Diabetic Retinopathy

•

Medical Studies

•

Retinopathy

•

Retina Subspecialty Day

Up Next

Gene Therapy for Wet AMD

Gene Therapy for Wet AMD

Szilard Kiss, MD

Anti-VEGF for Radiation Retinopathy

Anti-VEGF for Radiation Retinopathy

Amy C. Schefler, MD

Anatomy and Function in Major Comparative Trials

Anatomy and Function in Major Comparative Trials

Usha Chakravarthy, MBBS, PhD

ABC to Block VEGF-A Isoforms

ABC to Block VEGF-A Isoforms

Charles C. Wykoff, MD, PhD

Surgery for Viral Retinitis

Surgery for Viral Retinitis

J. Fernando Arevalo, MD, PhD, FACS

Managing LASIK Complications

Managing LASIK Complications

Sonia Yoo, MD

Understanding Percent Tissue Altered as a Risk Factor for Ectasia After Excimer Laser Surgery

Understanding Percent Tissue Altered as a Risk Factor for Ectasia After Excimer Laser Surgery

Marcony R. Santhiago, MD, PhD

Clinical Use of Cenegermin-bkbj Ophthalmic Solution for NK

Clinical Use of Cenegermin-bkbj Ophthalmic Solution for NK

Giacomina Massaro-Giordano, MD

Residual Astigmatism After Toric IOL Implantation

Residual Astigmatism After Toric IOL Implantation

George O. Waring IV, MD, FACS

Surgery for Normal-Pressure Glaucoma: Is There a Role for MIGS Before Filtering Surgery?

Surgery for Normal-Pressure Glaucoma: Is There a Role for MIGS Before Filtering Surgery?

Leonard K. Seibold, MD,

How Much Medication Is Too Much?

How Much Medication Is Too Much?

Janet Serle, MD

Iridocorneal Endothelial Syndrome

Iridocorneal Endothelial Syndrome

Lauren S. Blieden, MD

Managing Intraoperative Cataract Surgery Complications in Eyes With Glaucoma

Managing Intraoperative Cataract Surgery Complications in Eyes With Glaucoma

Shakeel Shareef, MD

Key Results From the Bimatoprost SR Phase 3 Study

Key Results From the Bimatoprost SR Phase 3 Study

Randy Craven, MD

Gender Equality Strategies in Today's Workforce

Gender Equality Strategies in Today's Workforce

Luxme Hariharan, MD

Social Media for Ophthalmologists

Social Media for Ophthalmologists

Ashley Brissette, MD

Evaluating Visual Performance of Small-Aperture, Accommodating, and Multifocal IOLs

Evaluating Visual Performance of Small-Aperture, Accommodating, and Multifocal IOLs

Jay S. Pepose, MD, PhD

$Advanced Diagnostics in Refractive Surgery: Epithelial Mapping and Phakic IOL Sizing$

Advanced Diagnostics in Refractive Surgery: Epithelial Mapping and Phakic IOL Sizing

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

IOL Implantation in the Absence of Zonular Support

IOL Implantation in the Absence of Zonular Support

Joanne F. Shen, MD

Starting a Career as a Clinician Scientist in Ophthalmology

Starting a Career as a Clinician Scientist in Ophthalmology

Alex Huang, MD

Mindfulness and Movement for Ophthalmologists

Mindfulness and Movement for Ophthalmologists

Jullia A. Rosdahl, MD, PhD

Top Ophthalmic Applications to Use in Your Practice

Top Ophthalmic Applications to Use in Your Practice

Lisa Nijm, MD, JD

Preventing Vision Loss in Keratoconus

Preventing Vision Loss in Keratoconus

Michael W. Belin, MD

Efficacy of Presbyond for the Correction of Presbyopia

Efficacy of Presbyond for the Correction of Presbyopia

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

Autonomous AI in Ophthalmology

Autonomous AI in Ophthalmology

Michael D. Abramoff, MD, PhD

CXL for Infectious Keratitis

CXL for Infectious Keratitis

Farhad Hafezi, MD, PhD, FARVO

MIGS and Medications

MIGS and Medications

Alex Huang, MD

Controlling Wound Healing Following PRK

Controlling Wound Healing Following PRK

Farhad Hafezi, MD, PhD, FARVO

MIGS in Patients With Corneal Disease

MIGS in Patients With Corneal Disease

John P. Berdahl, MD

The Latest Trends in Dry Eye Disease Management

The Latest Trends in Dry Eye Disease Management

Audrey R. Talley Rostov, MD

A New Anti-VEGF Option

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS

Hypersonic Vitrectomy Update

Hypersonic Vitrectomy Update

Carl C. Awh, MD

Iris Pigmented Tumors: When to Worry

Iris Pigmented Tumors: When to Worry

Carol L. Shields, MD

Surgical Repair of Retinal Detachment

Surgical Repair of Retinal Detachment

Mark W. Johnson, MD

Back to All Videos

PANORAMA Study Data

Rishi P. Singh, MD

Rishi P. Singh, MD, reviews 52-week data from the PANORMA study, which assessed response to therapy in patients with nonproliferative diabetic retinopathy without diabetic macular edema who were treated with aflibercept. Patients were treated every 8 or 16 weeks with aflibercept or sham and were evaluated for 2-step improvements in retinopathy scoring.

Posted: 9/13/2019

Keywords:

aflibercept

•

Diabetic macular edema, DME

•

Diabetic Retinopathy

•

Medical Studies

•

Retinopathy

•

Retina Subspecialty Day

Please log in to leave a comment.

More From AAO: 2019 Coverage

A New Anti-VEGF Option

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS

Hypersonic Vitrectomy Update

Hypersonic Vitrectomy Update

Carl C. Awh, MD

Iris Pigmented Tumors: When to Worry

Iris Pigmented Tumors: When to Worry

Carol L. Shields, MD

Surgical Repair of Retinal Detachment

Surgical Repair of Retinal Detachment

Mark W. Johnson, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2019.